![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire](https://mms.businesswire.com/media/20171130006320/en/627349/5/FMI_Exterior_for_Press_Kit.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
Foundation Medicine, Epic collaboration focuses on genomics for precision oncology | Healthcare IT News
![Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development | Business Wire Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development | Business Wire](https://mms.businesswire.com/media/20230411005419/en/794671/23/FMI_horizontal.jpg)